TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,301,000 | +19.5% | 400,953 | -0.6% | 0.05% | +13.3% |
| Q2 2016 | $4,436,000 | -5.9% | 403,253 | -0.2% | 0.04% | -13.5% |
| Q1 2016 | $4,714,000 | -3.1% | 404,253 | -2.3% | 0.05% | -7.1% |
| Q4 2015 | $4,866,000 | -5.6% | 413,753 | -8.2% | 0.06% | -9.7% |
| Q3 2015 | $5,155,000 | -26.3% | 450,593 | +16.4% | 0.06% | -23.5% |
| Q2 2015 | $6,990,000 | +27.6% | 387,051 | +18.5% | 0.08% | +20.9% |
| Q1 2015 | $5,480,000 | -41.9% | 326,751 | -39.4% | 0.07% | -5.6% |
| Q4 2014 | $9,434,000 | +170.5% | 538,802 | +173.6% | 0.07% | +16.4% |
| Q3 2014 | $3,488,000 | -14.0% | 196,951 | +11.9% | 0.06% | -18.7% |
| Q2 2014 | $4,054,000 | +21.3% | 176,028 | +27.6% | 0.08% | +5.6% |
| Q1 2014 | $3,343,000 | -9.4% | 137,950 | -6.0% | 0.07% | -43.7% |
| Q4 2013 | $3,688,000 | +96.3% | 146,700 | +31.6% | 0.13% | +152.0% |
| Q2 2013 | $1,879,000 | – | 111,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |